nervous system
|
• absence of the the fluoxetine-induced increase in survival of newborn neurons that is seen in wild-type controls
|
|
• absence of the fluoxetine-induced increase in neuronal precursor proliferation that is seen in wild-type controls
|
behavior/neurological
|
• fail to show a decrease in latency to feed in response to fluoxetine treatment in a novelty suppressed feeding assay, unlike wild-type controls
|
cellular
|
• absence of the fluoxetine-induced increase in neuronal precursor proliferation that is seen in wild-type controls
|